The American Conference Institute (ACI) is hosting its 6th Annual Summit on Life Sciences IP Due Diligence this November 28-29 in Boston, Massachusetts. This two-day summit is specifically designed to provide corporate and intellectual property counsel with the knowledge and strategies they need to effectively assess, value, and commercialize intellectual property assets during strategic IP due diligence. Performing IP due diligence in a correct and thorough manner is critical to most corporate transactions, and this event serves as an effective platform for delegates to gain practical insights and best practices.
ACI’s esteemed panel of speakers will provide invaluable insights into the intricacies of the due diligence process. They will specifically address critical aspects like what type of data to look for, when to report findings, effective communication strategies within and across teams, and circumstances that might mandate the adjustment of expectations. Each of these factors plays a key role in making IP due diligence a success, and delegates can look forward to deep dives into all of these essential considerations.
Events such as the 6th Annual Summit on Life Sciences IP Due Diligence play a crucial role in the components of the legal and business world converging. They provide an opportunity for professionals to stay updated and build their network, while learning how to unlock value from their intellectual property assets, ensure compliance, and reduce the associated risks. Given the increasing importance of IP in today’s digital world, it is more important than ever for legal professionals to stay ahead of the game and gain the skills to navigate with confidence in this field.